Mid America Clinical Labs is categorized under Medical Labs in Indianapolis, IN and active since 2010.
Mid America Clinical Labs was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Marcia Liebel at the company’s single location by writing to 10122 East 10th St # 200, Indianapolis, Indiana IN 46229 or by phoning (317) 355-2133. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mid America Clinical Labs |
| Contact Person: | Marcia Liebel |
| Address: | 10122 East 10th St # 200, Indianapolis, Indiana 46229 |
| Phone Number: | (317) 355-2133 |
| Website Address: | macl1.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 6215110 |
| Share This Business: |
Mid America Clinical Labs was started in 2010 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Marcia Liebel for inquiries that concern Mid America Clinical Labs by calling the company number (317) 355-2133, as your correspondence is most welcome. Additionally, the physical location of the single location of Mid America Clinical Labs can be found at the coordinates 39.78239,-85.98747 as well as the street address 10122 East 10th St # 200 in Indianapolis, Indiana 46229.
For its online presence, you may visit Mid America Clinical Labs’s website at macl1.com and engage with its social media outlets through on Twitter and on Facebook.